Vol. 14 No. 4 | April 2014

Vol. 14 No. 4 | April 2014

ISBN: 1526-5161

target articles

Is There an Ethical Obligation to Disclose Controversial Risk? A Question From the ACCORD Trial

Joseph P. DeMarco, Paul J. Ford, Dana J. Patton & Douglas O. Stewart

Researchers designing a clinical trial may be aware of disputed evidence of serious risks from previous studies. These researchers must decide whether and how to describe these risks in their model informed consent document. They have an ethical obligation to provide fully informed consent, but does this obligation include notice of controversial evidence? With ACCORD as an example, we describe a ...

Click for More

A number of philosophers working in applied ethics and bioethics are now earnestly debating the ethics of what they term “moral bioenhancement.” I argue that the society-wide program of biological manipulations required to achieve the purported goals of moral bioenhancement would necessarily implicate the state in a controversial moral perfectionism. Moreover, the prospect of being able to rel...

Click for More

editorial.